Stock · US92532F1003

Vertex Pharmaceuticals

Held by 3 schemes worth ₹110 Cr in Sept 2026.

Schemes holding Vertex Pharmaceuticals^{(Oct 2012 – Sept 2026)}

Schemes holding Vertex Pharmaceuticals in Sept 2026. Tick up to 2 to plot them.
Plot	3 schemes ·	₹ Cr
	Motilal Oswal Nasdaq 100 ETF	79.8
	ICICI Prudential Nasdaq 100 Index Fund	20.8
	Motilal Oswal S&P 500 Index Fund	9.2

Market value of Vertex Pharmaceuticals in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Motilal Oswal Nasdaq 100 ETF	ICICI Prudential Nasdaq 100 Index Fund
Sept 2025	₹58.2 Cr	₹13.7 Cr
Oct 2025	₹63.2 Cr	₹14.9 Cr
Nov 2025	₹65 Cr	₹15.2 Cr
Dec 2025	₹71 Cr	₹16.6 Cr
Jan 2026	₹73.2 Cr	₹17.3 Cr
Feb 2026	₹76.2 Cr	₹19 Cr
Mar 2026	₹70.4 Cr	₹17.8 Cr
Apr 2026	₹67.7 Cr	₹17.2 Cr
May 2026	₹70.7 Cr	₹18.1 Cr
Jun 2026	₹77.1 Cr	₹19.7 Cr
Jul 2026	₹74.9 Cr	₹18.9 Cr
Aug 2026	₹84.1 Cr	₹21.8 Cr
Sept 2026	₹79.8 Cr	₹20.8 Cr

Fig. 1.Market value of Vertex Pharmaceuticals in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 2.What mutual funds hold of this company, by fund house, by scheme type and by scheme. Hover a slice or a row; click a slice to open it.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.